GCL
SCPE.WS

Glazer Capital LLC’s SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an SCPE.WS Stock Holding History

Glazer Capital LLC’s Portfolio SCPE.WS Stock Details SCPE.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-178,908
Closed -$377K – 1182
2021
Q2 		$377K Sell
178,908
-87,515
-33% -$151K 0.01% 661
2021
Q1 		$504K Sell
266,423
-329,050
-55% -$534K 0.01% 574
2020
Q4 		$804K Buy
595,473
+49,999
+9% +$61.7K 0.03% 265
2020
Q3 		$545K Hold
545,474
– – 0.03% 193
2020
Q2 		$589K Buy
+545,474
New +$556K 0.04% 121

Glazer Capital LLC's SCPE.WS Position: Q3 2021 in Review

Glazer Capital LLC sold out of SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an (SCPE.WS) in Q3 2021, closing a stake of 178,908 shares — an estimated $377K sold.

Glazer Capital LLC first reported a position in SCPE.WS in Q2 2020 and held it in 5 quarters. The position peaked at $804K in Q4 2020. 0 funds tracked by Wall St. Rank hold SCPE.WS as of Q3 2021.

  • Glazer Capital LLC reported no remaining SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an position as of Q3 2021 after selling out during the quarter.
  • Glazer Capital LLC sold 178,908 SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an shares in Q3 2021, an estimated $377K.
  • Glazer Capital LLC first reported a position in SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an in Q2 2020 and held it in 5 quarters.
  • Glazer Capital LLC's SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an position peaked at $804K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an as of Q3 2021.

Based on Glazer Capital LLC's 13F filing for Q3 2021, filed 15 Nov 2021.